Solar generates more energy than coal in US for 1st time: Report - ABC News - Ivar AI - Najlepsza sztuczna inteligencja do inwestycji krajowych i międzynarodowych

The Times of India

US stocks: SpaceX to make historic listing on Nasdaq on Friday that could make Elon Musk a trillionaire

BusinessLine

SpaceX IPO pushes Elon Musk’s net worth past $1 trillion

KQED

SpaceX Blasts Off With a Record-Breaking $75 Billion IPO

The Daily Caller

US Attacks Iran After Trump Vowed Response To Lost Helicopter

Elespanol.com

El BCE sube los tipos por primera vez en tres años hasta el 2,25% para contener la inflación provocada por la guerra de Irán

Yahoo Entertainment

美科技巨頭 IPO 潮達 3.6 兆美元 SpaceX 募資恐吸走加密市場資金

Patronlardunyasi.com

IMF, Orta Doğu'daki savaşın Euro Bölgesi ekonomisine riskleri konusunda uyardı

Crypto Briefing

Iran confirms memorandum of understanding with US in final stages

El Financiero

Histórico ‘despegue’ para SpaceX: Recauda 75 mil mdd tras debutar en bolsa y dispara la fortuna de Musk

Biztoc.com

Elon Musk's SpaceX soars 20% in blockbuster Nasdaq debut

Yahoo Entertainment

四大AI巨頭籌資規模空前超越美五年IPO市場總和

Latercera.com

SpaceX confirma precio de colocación y se convertiría en la mayor apertura bursátil de la historia

BusinessLine

US inflation climbs to 4.2% and hits 3-year high amid rising fuel costs

Crypto Briefing

SpaceX prices record IPO at $135 per share, raising $75B in largest public offering ever

Macdailynews.com

Apple’s iPhone momentum shines bright: 19.7% YoY production surge positions it for market leadership amid industry headwinds

Crypto Briefing

Iran strikes US vessels near Strait of Hormuz with missiles and drones

BBC News

Live: US striking Iran in response to downing of helicopter, military says

RTE

US strikes Iran as Tehran warns of response to attacks

The Punch

NGX gains N830bn as Airtel Africa leads market rally

HuffPost

Republicans Back Escalation Of Iran War If That's What Trump Wants

$Cellectis reçoit le statut RMAT de la FDA pour lasmé-cel, la première thérapie CAR-T allogénique en essai pivot pour les patients atteints de LLA-B en rechute ou réfractaire$

GlobeNewswire

Cellectis reçoit le statut RMAT de la FDA pour lasmé-cel, la première thérapie CAR-T allogénique en essai pivot pour les patients atteints de LLA-B en rechute ou réfractaire